• Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Greece Italy +2
  • Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Denmark France Greece Italy The Netherlands +2
  • Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Denmark Estonia France +10
  • Comparing tarlatamab with standard chemotherapy in patients with pre-treated advanced pulmonary or gastroenteropancreatic neuroendocrine carcinomas

    Recruiting

    3 1 1 1
    France
  • Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

    Recruiting

    1 1 1 1
    Germany Italy Poland
  • Study of XL092 and belzutifan combination therapy in people with clear cell kidney cancer who had disease return during or after immunotherapy treatment

    Recruiting

    1 1 1
    France Poland Spain
  • Study of colchicine to improve insulin sensitivity in adults with type 1 diabetes who have low-grade inflammation

    Recruiting

    2 1 1
    Investigated Diseases:
    Denmark
  • Study comparing low and standard doses of Indocyanine Green for fluorescence imaging during gallbladder removal surgery in patients with gallstones

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain
  • Study of cefadroxil effectiveness in adult patients with Staphylococcus aureus bloodstream infection

    Recruiting

    2 1 1 1
    Belgium
  • Comparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

powered by